160 related articles for article (PubMed ID: 33360772)
1. Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.
Kozar N; Kruusmaa K; Dovnik A; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Takač I; Arko D
Adv Med Sci; 2021 Mar; 66(1):46-51. PubMed ID: 33360772
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Diagnostic Biomarkers in Breast Cancer Using Targeted Metabolomic Profiling.
Kozar N; Kruusmaa K; Bitenc M; Argamasilla R; Adsuar A; Takač I; Arko D
Clin Breast Cancer; 2021 Jun; 21(3):e204-e211. PubMed ID: 33281038
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer.
Kozar N; Kruusmaa K; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Arko D; Takač I
Clin Chim Acta; 2018 Jun; 481():108-114. PubMed ID: 29481776
[TBL] [Abstract][Full Text] [Related]
5. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer.
Knific T; Vouk K; Smrkolj Š; Prehn C; Adamski J; Rižner TL
J Steroid Biochem Mol Biol; 2018 Apr; 178():312-321. PubMed ID: 29360580
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic Signature of Endometrial Cancer.
Troisi J; Sarno L; Landolfi A; Scala G; Martinelli P; Venturella R; Di Cello A; Zullo F; Guida M
J Proteome Res; 2018 Feb; 17(2):804-812. PubMed ID: 29235868
[TBL] [Abstract][Full Text] [Related]
7. Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.
Chen J; Lu H; Cao D; Sun J; Qi F; Liu X; Liu J; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Wang T; Shen K; Sun W
Metabolomics; 2024 Jan; 20(1):18. PubMed ID: 38281200
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.
Bayci AWL; Baker DA; Somerset AE; Turkoglu O; Hothem Z; Callahan RE; Mandal R; Han B; Bjorndahl T; Wishart D; Bahado-Singh R; Graham SF; Keidan R
Metabolomics; 2018 Aug; 14(8):105. PubMed ID: 30830422
[TBL] [Abstract][Full Text] [Related]
9. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
[TBL] [Abstract][Full Text] [Related]
10. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract][Full Text] [Related]
11. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
12. Prospective analysis of circulating metabolites and endometrial cancer risk.
Dossus L; Kouloura E; Biessy C; Viallon V; Siskos AP; Dimou N; Rinaldi S; Merritt MA; Allen N; Fortner R; Kaaks R; Weiderpass E; Gram IT; Rothwell JA; Lécuyer L; Severi G; Schulze MB; Nøst TH; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Gurrea AB; Schmidt JA; Palli D; Agnoli C; Tumino R; Sacerdote C; Mattiello A; Vermeulen R; Heath AK; Christakoudi S; Tsilidis KK; Travis RC; Gunter MJ; Keun HC
Gynecol Oncol; 2021 Aug; 162(2):475-481. PubMed ID: 34099314
[TBL] [Abstract][Full Text] [Related]
13. Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS.
Shao X; Wang K; Liu X; Gu C; Zhang P; Xie J; Liu W; Sun L; Chen T; Li Y
Clin Chim Acta; 2016 Dec; 463():200-206. PubMed ID: 27784637
[TBL] [Abstract][Full Text] [Related]
14. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
15. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic Profiling of Plasma from Patients with Tuberculosis by Use of Untargeted Mass Spectrometry Reveals Novel Biomarkers for Diagnosis.
Lau SK; Lee KC; Curreem SO; Chow WN; To KK; Hung IF; Ho DT; Sridhar S; Li IW; Ding VS; Koo EW; Wong CF; Tam S; Lam CW; Yuen KY; Woo PC
J Clin Microbiol; 2015 Dec; 53(12):3750-9. PubMed ID: 26378277
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women.
Troisi J; Raffone A; Travaglino A; Belli G; Belli C; Anand S; Giugliano L; Cavallo P; Scala G; Symes S; Richards S; Adair D; Fasano A; Bottigliero V; Guida M
JAMA Netw Open; 2020 Sep; 3(9):e2018327. PubMed ID: 32986110
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential serum markers for endometrial cancer using protein expression profiling.
Takano M; Kikuchi Y; Asakawa T; Goto T; Kita T; Kudoh K; Kigawa J; Sakuragi N; Sakamoto M; Sugiyama T; Yaegashi N; Tsuda H; Seto H; Shiwa M
J Cancer Res Clin Oncol; 2010 Mar; 136(3):475-81. PubMed ID: 19756734
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Diagnostic Accuracies of Serum HE-4 Levels and 3D Power Doppler Angiography Parameters between Benign Endometrial Pathologies and Endometrial Cancer.
Erenel H; Bese T; Sal V; Demirkiran F; Arvas M
Asian Pac J Cancer Prev; 2016; 17(5):2507-11. PubMed ID: 27268621
[TBL] [Abstract][Full Text] [Related]
20. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
